Oncological outcomes of intraperitoneal chemotherapy in advanced ovarian cancer: BRCA mutation role.
Padilla-Iserte P, Iváñez M, Muruzabal JC, Navarro R, Díaz-Feijoo B, Iacoponi S, García-Pineda V, Díaz C, Utrilla-Layna J, Gil-Moreno A, Serra A, Gilabert-Estellés J, Martínez Canto C, Tejerizo Á, Lago V, Cárdenas-Rebollo JM, Domingo S; SEGO Spain-GOG Group.
Padilla-Iserte P, et al. Among authors: serra a.
Eur J Surg Oncol. 2024 Apr;50(4):108263. doi: 10.1016/j.ejso.2024.108263. Epub 2024 Mar 9.
Eur J Surg Oncol. 2024.
PMID: 38492526